Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G, Boerwinkle E
Institute for Medical Biology and Genetics, University of Innsbruck, Austria.
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4171-4. doi: 10.1073/pnas.86.11.4171.
The lipoprotein (a) [Lp(a)] contains two nonidentical protein species, apolipoprotein (apo) B-100 and a specific high molecular weight glycoprotein, apo(a). Lp(a) represents a continuous quantitative genetic trait, the genetics of which are only poorly understood. Genetic variation at the apo(a) locus affects plasma Lp(a) levels and explains at least 40% of the variability of this trait. Lp(a) levels were found to be elevated 3-fold in the plasma from patients with the heterozygous form of familial hypercholesterolemia who have one mutant low density lipoprotein receptor gene. This elevation was not due to a higher frequency of those apo(a) types that are associated with high Lp(a) levels in familial hypercholesterolemia patients. Rather Lp(a) levels were elevated for each of the apo(a) phenotypes examined. The effects of the apo(a) and low density lipoprotein receptor genes on Lp(a) levels are not additive but multiplicative. This is a situation not commonly considered in quantitative human genetics. We conclude that Lp(a) levels in plasma may be determined by variation at more than one gene locus.
脂蛋白(a)[Lp(a)]包含两种不同的蛋白质成分,即载脂蛋白(apo)B - 100和一种特定的高分子量糖蛋白,即载脂蛋白(a)。Lp(a)代表一种连续的数量遗传性状,其遗传学机制目前了解甚少。载脂蛋白(a)基因座的遗传变异会影响血浆Lp(a)水平,并且至少解释了该性状40%的变异性。研究发现,患有杂合型家族性高胆固醇血症且有一个突变型低密度脂蛋白受体基因的患者血浆中Lp(a)水平升高了3倍。这种升高并非是由于在家族性高胆固醇血症患者中与高Lp(a)水平相关的那些载脂蛋白(a)类型的频率更高。相反,对于所检测的每种载脂蛋白(a)表型,Lp(a)水平均升高。载脂蛋白(a)基因和低密度脂蛋白受体基因对Lp(a)水平的影响并非相加作用,而是相乘作用。这种情况在人类数量遗传学中并不常见。我们得出结论,血浆中Lp(a)水平可能由多个基因座的变异所决定。